Novotech Drug Development Consulting

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.   Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006. The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice. 

For more information or to speak to an expert team member visit www.Novotech-CRO.com

Sequoia Capital

Novotech

Happy Lunar New Year! Best wishes for a successful and prosperous Year of the Dragon. May this year bring continued advancements and achievements in the field of Clinical Trials. Here's to another year of meaningful contributions to healthcare and research excellence! 

#LunarNewYear #ClinicalTrials #YearOfTheDragon

On World Cancer Day, Novotech, affirms its commitment to working with biotechs worldwide to advance breakthroughs in cancer treatment.   

#CloseTheCareGap #WorldCancerDay #ClinicalTrials

The #Novotech team had an amazing time engaging with the clinical research community at last week’s 17th Annual ISCR Conference in India!

If you missed the chance to visit us during the conference, connect with us here- https://lnkd.in/gk8sj5HE

Bableen Sethi, Kanhaiya Choudhary 

#ISCRConference #ClinicalResearch #Innovation

In a recent visit, Dr. John Moller, CEO of Novotech, and Dr. Yooni Kim, Global Vice President and Head of Clinical Services, had the opportunity to engage with Lee Seung Kyou, Vice Chairman of Korea Bio. The organization is dedicated to strengthening connections within the bioindustry, reinvigorating related companies by actively promoting technological development and industrialization to foster the growth of the national economy. According to Korea Bio, “As of 2022, South Korea had a total of 1,089 biotech companies”. Novotech looks forward to sustaining its longstanding relationship in South Korea and continuing its support for the biotech industry.

#clinicalresearch #KoreaBio

In honor of Black History Month, let’s celebrate the pioneering achievements of African American scientists and doctors who’ve made lasting impacts on healthcare and scientific advancements.

#blackhistorymonth #clinicaltrials #clinicalresearch

In this enlightening interview, Passant Zaki, the Associate Director of Clinical Operations at Novotech, shared her inspiring professional journey through progressively advancing roles in clinical trial management. Her compelling career path underscored a harmonious blend of hands-on experience, education, and an unwavering dedication to continuous learning.

Also Passant perspectives offer a glimpse into the challenges and vast potential impact of advancing new therapies through dedicated leadership in healthcare research.
Watch it now!

#ClinicalResearchAssociate #Clinicaltials #CRA #closethecaregap

Stop by booth #6 at the India Society for Clinical Research (ISCR) 17th Annual Conference taking place today and tomorrow in Hyderabad, India and connect with the Novotech team! Discover how our expertise can elevate your clinical trial plans in 2024 and beyond.

Bableen Sethi, Kanhaiya Choudhary

#ISCR2024 #ClinicalTrials #CRO

Novotech’s CEO, Dr. John Moller, recently met with the newly appointed Australian Ambassador to the Republic of Korea, Mr. Jeff Robinson. Accompanying him were key members from the Novotech team, Dr. Yooni Kim, Global Vice President, Head of Clinical Services and Lilian K., Senior Director Business Development. 

A fruitful discussion ensued with Ambassador Robinson recognizing Novotech as a leading global CRO with headquarters in Australia. Both parties look forward to creating a synergistic relationship in the Republic of Korea.

#AusTrade #ClinicalTrials #CRO

Novotech is thrilled to announce our sponsorship for the upcoming OCT West Coast conference, happening on February 6-7 in Burlingame, California.

Join us at 𝐁𝐨𝐨𝐭𝐡 𝟕𝟔, where our experts will be available to discuss customized solutions that can fast-track the advancement of your #clinicaltrials.

Click here to get in touch with our experts- https://lnkd.in/gFqhvEAN

Diana Filipescu, Aditya Kotta, Rod Bugawan, Alex Ireland
#OCTWestCoast #CRO #DrugDevelopment

Agilex Biolabs is a contract research organization specializing in bioanalytical services for the pharmaceutical and biotech industries.

Agilex Biolabs

Avance Clinical is a contract research organization offering clinical research services for the pharmaceutical and biotech sectors.

Avance Clinical

360biolabs is a company providing comprehensive laboratory services for the pharmaceutical and biotech industries.

360biolabs

George Clinical Pty Ltd is a contract research organization offering clinical development services across various trial phases for the pharmaceutical and biotech industries.

George Clinical Pty Ltd

Antengene is a biopharmaceutical company focused on developing and commercializing innovative therapies for cancer patients.

Antengene

Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.

news impact assignment basic	general	Mar 8, 2024 1:47 AM	f637dd3e
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 1:47 AM	805524f6
company summary	general
signals	general	Mar 8, 2024 1:47 AM	a529d15d
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 8, 2024 1:47 AM	f10eb404
translate crunchbase fundingrounds	general
peers	general	Mar 8, 2024 1:47 AM	2005ce53
news basic	general	Mar 8, 2024 1:47 AM	93a78ad9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:NOVOTECH-CRO

Novotech